Dystocia: Clinical Trials

16 trials for Dystocia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 recruiting, 2 unknown, 2 withdrawn. 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 416Completed 9, Recruiting 2, Unknown 2, Withdrawn 2, Not yet recruiting 1

Follow Dystocia: new trials by email Literature Review of Dystocia trials Research Report on Dystocia

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial
Carbetocin, Oxytocin, Placebo Saline Infusion - Postpartum Hemorrhage, Uterine Atony
Phase 4RecruitingMansoura University3322026-08-082026-10-09
Oxytocin Bolus Versus Infusion in High-Risk Patients Undergoing Elective Cesarean Section (INBOX-HR)
Oxytocin Bolus or Oxytocin Infusion - Postpartum Hemorrhage, Uterine Atony
Phase 4Not yet recruitingStony Brook University1802026-08-012026-08-03
Calcium Carbonate to Augment Labor Contractions
Calcium Carbonate 500 MG, Standard Dose Synthetic Pitocin - Labor Dystocia, Labor Induction
Phase 4RecruitingWeill Medical College of Cornell University602024-11-182025-10-23
Comparison Between Propess and Cook Double-balloon Catheter for Cervical Priming
Cook double-balloon catheter - Delivery Problem
Phase 4UnknownThe University of Hong Kong282024-06-012024-07-24
Multimodal Uterotonics at the Time of Cesarean Section in Laboring Patients
Methylergonovine, Normal Saline (placebo) - Uterine Atony With Hemorrhage
Phase 4CompletedCynthia Wong1602019-06-082022-08-01
Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial
15-methyl prostaglandin F2α, Methylergonovine Maleate - Postpartum Hemorrhage, Uterine Atony
Phase 4CompletedBrigham and Women's Hospital1002019-03-012025-10-16
Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section
Tranexamic Acid, Intraoperative Uterine Cooling - Hemorrhage of Cesarean Section and/or Perineal Wound, Postpartum Hemorrhage
Phase 4CompletedTalkha Central Hospital1002016-06-012016-09-05
An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery
Oxytocin - Uterine Atony, Postpartum Hemorrhage
Phase 4WithdrawnNYU Langone Health2015-11-012017-07-31
Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation
Oxytocin, Sodium Chloride 0.9% - Dystocia
Phase 4CompletedNorthwestern University10032015-09-282022-02-11
Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section
Carbetocin - Uterine Atony, Post-partum Hemorrhage
Phase 4CompletedLaval University722012-04-012013-05-29
ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery
Carbetocin - Postpartum Hemorrhage, Uterine Atony
Phase 4UnknownMaisonneuve-Rosemont Hospital402012-03-012013-02-15
Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?
Oxytocin, Saline - Postpartum Hemorrhage, Uterine Atony
Phase 4WithdrawnUniversity of Saskatchewan2011-08-012012-01-11
Oxytocin And Uterotonic Agent Use For Cesarean Delivery
Oxytocin Infusion, Oxytocin Bolus - Uterine Atony, Hypotension
Phase 4CompletedBrigham and Women's Hospital602011-04-012017-06-29
Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT
Oxytocin - Uterine Atony, Postpartum Hemorrhage
Phase 4CompletedUniversity of Alabama at Birmingham17982008-11-012016-04-08
Up-Down Oxytocin Infusion
Oxytocin infusion - Uterine Atony
Phase 4CompletedIWK Health Centre402008-06-012011-11-02
Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage
Misoprostol, Folic Acid - Postpartum Hemorrhage
Phase 4CompletedHospital Universitario Dr. Jose E. Gonzalez1232008-02-012018-10-11

Narrower conditions

Uterine Inertia (13)  ·  Postpartum Hemorrhage (10)  ·  Blood Loss, Surgical (1)  ·  Hemorrhage (1)  ·  Hypotension (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (16)  ·  Obstetric Labor Complications (16)  ·  Pregnancy Complications (16)  ·  Urogenital Diseases (16)  ·  Pathologic Processes (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Hemorrhage (10)  ·  Puerperal Disorders (10)  ·  Uterine Hemorrhage (10)  ·  Cardiovascular Diseases (1)  ·  Intraoperative Complications (1)  ·  Vascular Diseases (1)

Interventions

Oxytocin (5)  ·  Methylergonovine (3)  ·  Sodium Chloride (3)  ·  carbetocin (3)  ·  Misoprostol (2)  ·  Saline Solution (2)  ·  Calcium Carbonate (1)  ·  Carboprost (1)  ·  Folic Acid (1)  ·  Tranexamic Acid (1)  ·  carboprost tromethamine (1)

Sponsors

Brigham and Women's Hospital (2)  ·  Cynthia Wong (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)  ·  IWK Health Centre (1)  ·  Laval University (1)  ·  Maisonneuve-Rosemont Hospital (1)  ·  Mansoura University (1)  ·  NYU Langone Health (1)  ·  Northwestern University (1)  ·  Stony Brook University (1)  ·  Talkha Central Hospital (1)  ·  The University of Hong Kong (1)  ·  University of Alabama at Birmingham (1)  ·  University of Saskatchewan (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (6)  ·  Canada (4)  ·  Egypt (1)  ·  Hong Kong (1)  ·  Mexico (1)  ·  Saudi Arabia (1)

Top investigators

Alan Peaceman, MD (1)  ·  Alan T Tita, MD, PhD (1)  ·  Amro M Hetta, M.B., Ch.B. (1)  ·  Christian Loubert, MD, FRCPC (1)  ·  David C Campbell, MD, FRCPC (1)  ·  Jade King, BS (1)  ·  Kevin Fitzpatrick, MD (1)  ·  Lawrence C Tsen, MD (1)  ·  Moeun Son, MD (1)  ·  Moeun Son, MD, MSCI (1)  ·  Mohamed A Tolba, MD (1)  ·  Monica K San Vicente, MD (1)  ·  Naida M Cole, MD (1)  ·  Nicole M Masse, MD (1)

Results publications

PMID 20238255, PMID 22227638, PMID 26534874, PMID 33232518, PMID 33957657, PMID 35852267, PMID 36649339, PMID 39326051

NIH funding

K12HD001258 (1)